$22.06
-0.45%AdvanSix Inc. manufactures and sells polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, alpha-methyl styrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide. It offers its products under the Aegis, Capra, Sulf-N, Nadone, Naxol, and EZ-Blox brands. The company sells its products directly, as well as through distributors. AdvanSix Inc. was incorporated in 2016 and is headquartered in Parsippany, New Jersey.
Acceptable liquidity, but monitor closely. Current assets just barely cover current liabilities.
Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.
Positive working capital, but relatively tight. The company should monitor cash flow carefully.
Capital-intensive business with significant long-term investments in property, equipment, or intangibles.
ASIX โข NYSE
| AdvanSix Inc. Balance Sheet | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ASSETS | ||||||||||||
CURRENT ASSETS | ||||||||||||
19.8M | 19.6M | 29.8M | 31M | 15.1M | 10.6M | 7.1M | 9.8M | 55.4M | 14.2M | 0.0 | 0.0 | |
19.8M | 19.6M | 29.8M | 31M | 15.1M | 10.6M | 7.1M | 9.8M | 55.4M | 14.2M | 0.0 | 6.4M | |
175.7M | 146.2M | 166.8M | 185.2M | 179.1M | 135.8M | 106.7M | 160.3M | 196M | 131.7M | 127.5M | 167.3M | |
152.7M | 140.7M | 154.4M | 171.3M | 174.1M | 120.9M | 105.3M | 158.6M | 187.1M | 116.3M | 126.5M | 165.2M | |
23M | 5.5M | 12.4M | 13.9M | 5M | 15M | 1.7M | 1.7M | 8.9M | 15.4M | 1M | 2.2M | |
236.5M | 212.4M | 211.8M | 215.5M | 149.6M | 180.1M | 171.7M | 137.2M | 129.2M | 129M | 150.2M | 155.3M | |
8.6M | 9M | 11.4M | 9.2M | 6.1M | 7M | 5.1M | 3.8M | 7.1M | 7.7M | 4.4M | 9.1M | |
440.6M | 387.1M | 419.8M | 440.9M | 349.9M | 333.5M | 290.5M | 311.1M | 387.8M | 282.5M | 282.2M | 331.7M | |
NON-CURRENT ASSETS | ||||||||||||
1.1B | 1.1B | 948.4M | 925.8M | 904.2M | 880M | 891.9M | 672.2M | 612.6M | 575.4M | 527.5M | 468.8M | |
56.2M | 56.2M | 56.2M | 56.2M | 17.6M | 15M | 15M | 15M | 15M | 15M | 15M | 15M | |
40.1M | 43.1M | 46.2M | 49.2M | 18M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
96.3M | 99.3M | 102.4M | 105.4M | 35.6M | 15M | 15M | 15M | 15M | 15M | 15M | 15M | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -103.8M | -92.3M | -114.2M | 0.0 | 0.0 | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 103.8M | 92.3M | 114.2M | 0.0 | 0.0 | |
41M | 37.2M | 25.4M | 23.2M | 22.4M | 34.9M | 38.6M | 36.3M | 34.9M | 32M | 16.2M | 7.6M | |
1.3B | 1.2B | 1.1B | 1.1B | 962.1M | 929.9M | 945.4M | 723.6M | 662.5M | 622.4M | 558.8M | 491.4M | |
1.7B | 1.6B | 1.5B | 1.5B | 1.3B | 1.3B | 1.2B | 1B | 1.1B | 905M | 841M | 823M | |
LIABILITIES | ||||||||||||
CURRENT LIABILITIES | ||||||||||||
284M | 229.8M | 267.1M | 272.8M | 221.2M | 190.2M | 205.9M | 231.7M | 227.7M | 223M | 192.7M | 232.8M | |
284M | 228.8M | 259.1M | 272.7M | 221.2M | 190.2M | 205.9M | 229.5M | 227.7M | 223M | 192.7M | 232.8M | |
1.1M | 1M | 8M | 30K | 0.0 | 0.0 | 0.0 | 2.2M | 1K | 0.0 | 0.0 | 0.0 | |
45.9M | 47.3M | 44.1M | 48.8M | 49.7M | 41.2M | 28.1M | 581K | 301K | 25.4M | 25.1M | 24.8M | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 16.9M | 0.0 | 0.0 | 0.0 | |
45.3M | 42.5M | 32.1M | 37.5M | 36.1M | 29.3M | 38M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
1.1M | 1M | 8M | 30K | 0.0 | 0.0 | 0.0 | 2.2M | 1K | 0.0 | 0.0 | 0.0 | |
14.5M | 37.5M | 15.7M | 34.4M | 2.7M | 26.4M | 19.7M | 22.6M | 17.2M | 25.6M | 25.2M | 32M | |
155K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 29.9M | 34.7M | 0.0 | 0.0 | 0.0 | |
390M | 357.1M | 358.9M | 393.5M | 309.8M | 287M | 291.7M | 284.7M | 296.8M | 274M | 243.1M | 289.5M | |
NON-CURRENT LIABILITIES | ||||||||||||
215M | 195M | 170M | 115M | 135M | 275M | 297M | 200M | 248.3M | 264.8M | 0.0 | 0.0 | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 21.1M | 33.4M | 33.5M | 0.0 | 0.0 | |
154.1M | 145.3M | 151.1M | 160.4M | 133.3M | 125.6M | 110.1M | 103.8M | 92.3M | 114.2M | 114.9M | 111.4M | |
9.5M | 11.5M | 12.8M | 10.7M | 32.1M | 46.1M | 37.9M | 25.8M | 36.5M | 36.6M | 4M | 5.3M | |
501M | 463.2M | 397.9M | 363.7M | 401M | 532.2M | 543.4M | 329.6M | 377.2M | 415.6M | 118.9M | 116.8M | |
167.7M | 153.9M | 96M | 115M | 136.7M | 114.9M | 136.4M | 671K | 0.0 | 0.0 | 0.0 | 0.0 | |
890.9M | 820.3M | 756.8M | 757.2M | 710.8M | 819.3M | 835.1M | 614.3M | 673.9M | 689.6M | 361.9M | 406.3M | |
SHAREHOLDERS' EQUITY | ||||||||||||
-63K | -63K | -58K | -45K | -36K | -36K | -35K | -12K | 0.0 | 0.0 | 0.0 | 0.0 | |
332K | 330K | 326K | 320K | 318K | 316K | 314K | 306K | 305K | 305K | 482.8M | 422M | |
142.9M | 136.9M | 138M | 174.6M | 195.9M | 184.7M | 180.9M | 234.7M | 263.1M | 242.8M | 0.0 | 0.0 | |
663M | 631.5M | 605.1M | 567.5M | 411.5M | 275.2M | 229.2M | 187.8M | 122M | -24.7M | 482.8M | 0.0 | |
9M | 6M | -4.1M | -4.2M | -6.5M | -16.1M | -9.5M | -2.5M | -9M | -3M | -3.7M | -5.2M | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -482.8M | 0.0 | |
815.2M | 774.7M | 739.2M | 738.2M | 601.2M | 444.1M | 400.9M | 420.3M | 376.3M | 215.4M | 479.1M | 416.8M | |
815.2M | 774.7M | 739.2M | 738.2M | 601.2M | 444.1M | 400.9M | 420.3M | 376.3M | 215.4M | 479.1M | 416.8M | |
SUMMARY | ||||||||||||
1.7B | 1.6B | 1.5B | 1.5B | 1.3B | 1.3B | 1.2B | 1B | 1.1B | 905M | 841M | 823M | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -103.8M | -92.3M | -114.2M | 0.0 | 0.0 | |
382.7M | 348.9M | 266M | 230M | 271.7M | 389.9M | 433.4M | 200M | 265.2M | 264.8M | 0.0 | 0.0 | |
362.9M | 329.3M | 236.2M | 199.1M | 256.6M | 379.3M | 426.3M | 190.2M | 209.8M | 250.6M | 0.0 | 0.0 | |
26,844,187 | 26,844,187 | 26,844,187 | 26,844,187 | 26,844,187 | 26,844,187 | 26,844,187 | 26,844,187 | 26,844,187 | 26,844,187 | 26,844,187 | 26,844,187 |
ASIX - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 08, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 08, 2026 | May 08, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 29, 2026 | June 22, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 13, 2026 | April 13, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 20, 2026 | February 20, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 20, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2025 N/A | December 22, 2025 | December 22, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 07, 2025 | November 07, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 07, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 23, 2025 | October 23, 2025 | 2025 |
Continue your ASIX research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.